Related references
Note: Only part of the references are listed.Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
Jackelyn Murray et al.
VIRUSES-BASEL (2022)
Bronchiolitis
Stuart R. Dalziel et al.
LANCET (2022)
Type III Interferons, Viral Loads, Age, and Disease Severity in Young Children With Respiratory Syncytial Virus Infection
Jeanette Taveras et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein
Harrison C. Bergeron et al.
VIRUSES-BASEL (2022)
Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies
Harrison C. Bergeron et al.
VIRUSES-BASEL (2021)
Immunopathology of RSV: An Updated Review
Harrison C. Bergeron et al.
VIRUSES-BASEL (2021)
High Dose IFN-β Activates GAF to Enhance Expression of ISGF3 Target Genes in MLE12 Epithelial Cells
Kensei Kishimoto et al.
FRONTIERS IN IMMUNOLOGY (2021)
CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats
Gia Green et al.
JOURNAL OF VIROLOGY (2021)
Functional Features of the Respiratory Syncytial Virus G Protein
Larry J. Anderson et al.
VIRUSES-BASEL (2021)
Assessment of Drug Resistance during Phase 2b Clinical Trials of Presatovir in Adults Naturally Infected with Respiratory Syncytial Virus
Danielle P. Porter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Emerging small and large molecule therapeutics for respiratory syncytial virus
Harrison C. Bergeron et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Up-to-date role of biologics in the management of respiratory syncytial virus
Seyhan Boyoglu-Barnum et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2020)
Respiratory Syncytial Virus's Non-structural Proteins: Masters of Interference
Elena Margaret Thornhill et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Efficacy and safety of interferon on neonates with respiratory syncytial virus pneumonia
Lingyun He et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
Evaluation of the respiratory syncytial virus G-directed neutralizing antibody response in the human airway epithelial cell model
Michael Kishko et al.
VIROLOGY (2020)
Shared and Distinct Functions of Type I and Type III Interferons
Helen M. Lazear et al.
IMMUNITY (2019)
Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus
Maria Jose Altamirano-Lagos et al.
FRONTIERS IN MICROBIOLOGY (2019)
Decoding type I and III interferon signalling during viral infection
Emily Mesev et al.
NATURE MICROBIOLOGY (2019)
Sources of Type I Interferons in Infectious Immunity: Plasmacytoid Dendritic Cells Not Always in the Driver's Seat
Shafaqat Ali et al.
FRONTIERS IN IMMUNOLOGY (2019)
Disruption of Type III Interferon (IFN) Genes Ifnl2 and Ifnl3 Recapitulates Loss of the Type III IFN Receptor in the Mucosal Antiviral Response
Stefan T. Peterson et al.
JOURNAL OF VIROLOGY (2019)
Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses
Koen Sedeyn et al.
PLOS PATHOGENS (2019)
Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity
Diego R. Hijano et al.
FRONTIERS IN IMMUNOLOGY (2019)
Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem
Ralph A. Tripp et al.
JOURNAL OF VIROLOGY (2018)
Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model
Hayat Caidi et al.
ANTIVIRAL RESEARCH (2018)
ISG15 in antiviral immunity and beyond
Yi-Chieh Perng et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies
Stanislav O. Fedechkin et al.
SCIENCE IMMUNOLOGY (2018)
The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection
Abhijeet A. Bakre et al.
VACCINES (2017)
Palivizumab Prophylaxis in Preterm Infants and Subsequent Recurrent Wheezing Six-Year Follow-up Study
Hiroyuki Mochizuki et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
The Human Immune Response to Respiratory Syncytial Virus Infection
Clark D. Russell et al.
CLINICAL MICROBIOLOGY REVIEWS (2017)
Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium
Remi Villenave et al.
JOURNAL OF VIROLOGY (2015)
Molecular basis for antagonistic activity of anifrolumab, an anti-interferon-alpha receptor 1 antibody
Li Peng et al.
MABS (2015)
An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice
Seyhan Boyoglu-Barnum et al.
VIROLOGY (2015)
Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures
Sara M. Johnson et al.
PLOS PATHOGENS (2015)
Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis
Raymond J. Pickles et al.
JOURNAL OF PATHOLOGY (2015)
Identification of Residues in the Human Respiratory Syncytial Virus Fusion Protein That Modulate Fusion Activity and Pathogenesis
Anne L. Hotard et al.
JOURNAL OF VIROLOGY (2015)
CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner
Kwang-Il Jeong et al.
PLOS ONE (2015)
Layer-By-Layer Nanoparticle Vaccines Carrying the G Protein CX3C Motif Protect against RSV Infection and Disease
Patricia A. Jorquera et al.
VACCINES (2015)
Type I interferons in infectious disease
Finlay McNab et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Interferon lambda 1-3 expression in infants hospitalized for RSV or HRV associated bronchiolitis
Carla Selvaggi et al.
JOURNAL OF INFECTION (2014)
Limited Type I Interferons and Plasmacytoid Dendritic Cells during Neonatal Respiratory Syncytial Virus Infection Permit Immunopathogenesis upon Reinfection
Stephania A. Cormier et al.
JOURNAL OF VIROLOGY (2014)
Prophylaxis with a Respiratory Syncytial Virus (RSV) Anti-G Protein Monoclonal Antibody Shifts the Adaptive Immune Response to RSV rA2-line19F Infection from Th2 to Th1 in BALB/c Mice
Seyhan Boyoglu-Barnum et al.
JOURNAL OF VIROLOGY (2014)
Effectiveness of Palivizumab in Preventing RSV Hospitalization in High Risk Children: A Real-World Perspective
Nusrat Homaira et al.
INTERNATIONAL JOURNAL OF PEDIATRICS (2014)
Regulation of type I interferon responses
Lionel B. Ivashkiv et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Suppression of cytokine signaling: The SOCS perspective
Edmond M. Linossi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2013)
Respiratory Syncytial Virus G Protein CX3C Motif Impairs Human Airway Epithelial and Immune Cell Responses
Tatiana Chirkova et al.
JOURNAL OF VIROLOGY (2013)
A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab′)2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice
Seyhan Boyoglu-Barnum et al.
JOURNAL OF VIROLOGY (2013)
Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease
Patricia A. Jorquera et al.
PLOS ONE (2013)
Respiratory Syncytial Virus Induced Type I IFN Production by pDC Is Regulated by RSV-Infected Airway Epithelial Cells, RSV-Exposed Monocytes and Virus Specific Antibodies
Marcel A. Schijf et al.
PLOS ONE (2013)
Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF
P. S. McNamara et al.
THORAX (2013)
Therapeutic targeting of respiratory syncytial virus G-protein
Lawrence M. Kauvar et al.
IMMUNOTHERAPY (2010)
Serum Antibodies Critically Affect Virus-Specific CD4+/CD8+ T Cell Balance during Respiratory Syncytial Virus Infections
Debby Kruijsen et al.
JOURNAL OF IMMUNOLOGY (2010)
Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naive and Formalin-Inactivated RSV-Immunized BALB/c Mice
Gertrud U. Radu et al.
JOURNAL OF VIROLOGY (2010)
Palivizumab: where to from here?
Georgiana Georgescu et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab′)2 components mediates reduced pulmonary inflammation in mice
Congrong Mao et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice
Lia M. Haynes et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
A Chimeric A2 Strain of Respiratory Syncytial Virus (RSV) with the Fusion Protein of RSV Strain Line 19 Exhibits Enhanced Viral Load, Mucus, and Airway Dysfunction
Martin L. Moore et al.
JOURNAL OF VIROLOGY (2009)
Respiratory Syncytial Virus Proteins Modulate Suppressors of Cytokine Signaling 1 and 3 and the Type I Interferon Response to Infection by a Toll-Like Receptor Pathway
Christine M. Oshansky et al.
VIRAL IMMUNOLOGY (2009)
RSV replication is attenuated by counteracting expression of the suppressor of cytokine signaling (SOCS) molecules
Koichi Hashimoto et al.
VIROLOGY (2009)
Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history
Patricia Fitzgerald-Bocarsly et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction
Masashi Shingai et al.
INTERNATIONAL IMMUNOLOGY (2008)
Respiratory syncytial virus (RSV) attachment and nonstructural proteins modify the type I interferon response associated with suppressor of cytokine signaling (SOCS) proteins and IFN-stimulated gene-15 (ISG15)
Elizabeth C. Moore et al.
VIROLOGY JOURNAL (2008)
Functional polymorphism in the suppressor of cytokine signaling 1 gene associated with adult asthma
Michishige Harada et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection
Hongwei Wang et al.
JOURNAL OF IMMUNOLOGY (2006)
Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics
Martin L. Moore et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy - a review
Yechiel Becker
VIRUS GENES (2006)
Respiratory syncytial virus(RSV)-induced allergy may be controlled by IL-4 and CX3C fractalkine antagonists and CpG ODN as adjuvant: hypothesis and implications for treatment
Yechiel Becker
VIRUS GENES (2006)
Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus
Nicholas W. Lukacs et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses
J Harcourt et al.
JOURNAL OF IMMUNOLOGY (2006)
Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections
A Guerrero-Plata et al.
JOURNAL OF VIROLOGY (2005)
Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness
MS Lo et al.
JOURNAL OF VIROLOGY (2005)
The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin
FP Polack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
Suppression of the induction of alpha, beta, and gamma interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages
KM Spann et al.
JOURNAL OF VIROLOGY (2004)
Suppressors of cytokine signalling (SOCS) in the immune system
WS Alexander
NATURE REVIEWS IMMUNOLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
RA Tripp et al.
NATURE IMMUNOLOGY (2001)
Protection against respiratory syncytial virus (RSV) elicited in mice by plasmid DNA immunisation encoding a secreted RSV G protein-derived antigen
C Andersson et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2000)
Share Paper
